116 related articles for article (PubMed ID: 36876711)
1. An investigation into the mechanism of nobiletin's inhibition of papillary thyroid cancer using network pharmacology analysis and experimental pharmacology.
Du QJ; Li Q; Zhou RH; Wang H; Yan Q; Dang WJ; Guo JJ
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1553-1564. PubMed ID: 36876711
[TBL] [Abstract][Full Text] [Related]
2. Anti-papillary thyroid carcinoma effects of dioscorea bulbifera L. through ferroptosis and the PI3K/AKT pathway based on network pharmacology and experimental validation.
Gao Y; Yang Z; Ji T; Zhou P; Geng L; Gao X
J Ethnopharmacol; 2024 May; 326():117912. PubMed ID: 38387682
[TBL] [Abstract][Full Text] [Related]
3. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the mechanism of Prunella vulgaris in treatment of papillary thyroid carcinoma based on network pharmacology integrated molecular docking and experimental verification.
Zhu X; Li Y; Wang X; Huang Y; Mao J
Medicine (Baltimore); 2023 Apr; 102(17):e33360. PubMed ID: 37115092
[TBL] [Abstract][Full Text] [Related]
5. [Mechanism of Marsdenia tenacissima against ovarian cancer based on network pharmacology and experimental verification].
Hu YJ; Wei LY; Zhao J; Zhu QF; Meng ZY; Meng JJ; Chen JJ; Xu LY; Zhou YY; Han YL
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(8):2222-2232. PubMed ID: 37282910
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
Wang YC; Hui JR; Xiao G; Ma QL
Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
[TBL] [Abstract][Full Text] [Related]
8. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
9. [Mechanism of Zhongfeng Xingnao Decoction in improving microcirculatory disorders in cerebral hemorrhage based on network pharmacology and molecular docking techniques].
Zhong XQ; Hu DF; Wang Y; Ning ZQ; Deng MZ
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6115-6127. PubMed ID: 38114219
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Study to Investigate the Tumor-Suppressive Role of
Lv L; Du J; Wang D; Yan Z
Drug Des Devel Ther; 2024; 18():375-394. PubMed ID: 38347958
[TBL] [Abstract][Full Text] [Related]
11. Exploring the mechanism of Erteng-Sanjie capsule in treating gastric and colorectal cancers via network pharmacology and in-vivo validation.
Zhang W; Wang Y; Yu H; Jin Z; Yuan Y; Liu L; Zhou J
J Ethnopharmacol; 2024 Jun; 327():117945. PubMed ID: 38428659
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism of n-butanol fraction of Wenxia Formula combining with gefitinib in treating non-small cell lung cancer based on network pharmacology and in vitro experiment].
Chen RJ; Bi QY; Shi JM; Zhong J; Han JT; Ji XM
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):471-486. PubMed ID: 38403323
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
14. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
[TBL] [Abstract][Full Text] [Related]
16. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
[TBL] [Abstract][Full Text] [Related]
17. The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
Li M; Zhang W; Yang L; Wang H; Wang Y; Huang K; Zhang W
Dis Markers; 2021; 2021():4304507. PubMed ID: 34306252
[TBL] [Abstract][Full Text] [Related]
18. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology.
Tu H; Feng Y; Wang W; Zhou H; Cai Q; Feng Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14413. PubMed ID: 38040415
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of active components of "Notoginseng Radix et Rhizoma-Drynariae Rhizoma" in treatment of osteoporosis based on network pharmacology and in vitro cell experiment].
Yang WJ; Huang J; Wang W; Peng LJ; Li JY; Zhu WF
Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(4):1087-1097. PubMed ID: 36872279
[TBL] [Abstract][Full Text] [Related]
20. To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments.
Sun Y; Xie W; Kang N; Yi J; Ruan X; Hu L; Zhao J; Zheng X; Wei S; Gao M
Dis Markers; 2022; 2022():9541080. PubMed ID: 36510497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
